US Broker Ratings

Valneva SE (VALN)

⚠️ No article content returned.

..

Verastem, Inc. (VSTM) Stock Analysis: A Biotech Gem with 71.20% Potential Upside

Verastem, Inc. (NASDAQ: VSTM), a development-stage biopharmaceutical company, is capturing investor interest with a potential upside of 71.20%, according to recent analyst ratings. With a focus..

Xeris Biopharma Holdings, Inc. (XERS) Stock Analysis: High Revenue Growth and Promising Potential Upside

For investors seeking opportunities in the healthcare sector, Xeris Biopharma Holdings, Inc. (XERS) presents an intriguing prospect. This commercial-stage biopharmaceutical company, based in Chicago, Illinois, focuses..

Butterfly Network, Inc. (BFLY) Stock Analysis: Evaluating a 63.97% Potential Upside in the Innovative Medical Device Sector

Butterfly Network, Inc. (NASDAQ: BFLY) stands at the forefront of innovation within the healthcare sector, specifically in the medical devices industry. Headquartered in Burlington, Massachusetts, the..

Community Health Systems, Inc. (CYH) Stock Analysis: Navigating Challenges with a 6.31% Upside Potential

In the complex landscape of healthcare investments, Community Health Systems, Inc. (NYSE: CYH) presents both challenges and opportunities for investors. With a current market cap of..

Gyre Therapeutics, Inc. (GYRE) Stock Analysis: Unveiling a Potential 218% Upside in Biotech Innovation

In the dynamic world of biotechnology, Gyre Therapeutics, Inc. (NASDAQ: GYRE) stands out as a key player with its focus on the development and commercialization of..

Collegium Pharmaceutical, Inc. (COLL) Stock Analysis: Potential Upside of Over 108% Amidst Strong Buy Ratings

Collegium Pharmaceutical, Inc. (NASDAQ: COLL), a prominent player in the healthcare sector, has been capturing investor attention with its compelling potential for upside. With a notable..

InnovAge Holding Corp. (INNV) Stock Analysis: Potential 26% Upside for Healthcare Investors

InnovAge Holding Corp. (NASDAQ: INNV) has carved out a niche in the healthcare sector by providing comprehensive medical and ancillary services to seniors. Operating under the..

Bioventus Inc. (BVS)

⚠️ No article content returned.

..

Capricor Therapeutics (CAPR): Investor Outlook on Potential 340% Upside in Biotechnology Innovation

Capricor Therapeutics, Inc. (NASDAQ: CAPR), a clinical-stage biotechnology company, promises to be a compelling consideration for investors with its impressive potential upside of 340.46%. This San..

Kura Oncology, Inc. (KURA) Stock Analysis: Examining a 222.98% Potential Upside in the Biotech Space

Kura Oncology, Inc. (NASDAQ: KURA), a clinical-stage biopharmaceutical company, is emerging as a prominent player in the healthcare sector, specifically within the biotechnology industry. Headquartered in..

STAAR Surgical Company (STAA) Stock Analysis: Eyeing a 23% Potential Upside in the Healthcare Sector

For investors navigating the medical instruments and supplies industry, STAAR Surgical Company (STAA) presents an intriguing opportunity, particularly with its potential upside of 23.02%. Positioned in..

Cronos Group Inc. (CRON) Stock Analysis: Exploring a 58.4% Revenue Growth Amidst Market Challenges

Cronos Group Inc. (NASDAQ: CRON) has captured investor attention with its robust revenue growth of 58.4%, a standout performance in the highly competitive cannabis industry. As..

Altimmune, Inc. (ALT) Stock Analysis: A Biotech Gem with 688% Potential Upside

Investors seeking high-reward opportunities in the biotechnology sector might find Altimmune, Inc. (NASDAQ: ALT) an intriguing prospect. With a staggering potential upside of 688.53%, according to..

Tyra Biosciences (TYRA) Stock Analysis: Unpacking a 127.38% Potential Upside in the Biotech Sector

Tyra Biosciences, Inc. (TYRA), a clinical-stage biotechnology firm based in Carlsbad, California, has captured investor attention with its innovative approach to developing precision medicines targeting fibroblast..

RxSight, Inc. (RXST) Stock Analysis: Exploring a 49% Upside Potential in the Medical Device Sector

RxSight, Inc. (RXST), a key player in the healthcare sector, presents an intriguing opportunity for investors with its innovative approach in the medical devices industry. Specializing..

Definitive Healthcare Corp. (DH) Stock Analysis: Exploring a Potential 75% Upside in a Challenging Market

Definitive Healthcare Corp. (NASDAQ: DH) is a key player in the healthcare sector, offering a cutting-edge Software as a Service (SaaS) platform that provides invaluable commercial..

Simulations Plus, Inc. (SLP)

⚠️ No article content returned.

..

Nuvation Bio Inc. (NUVB) Stock Analysis: A Biotech Play with 176.60% Upside Potential

For investors eyeing opportunities in the biotechnology sector, Nuvation Bio Inc. (NASDAQ: NUVB) presents a compelling narrative. As a clinical-stage biopharmaceutical company committed to innovative cancer..

Spyre Therapeutics, Inc. (SYRE)

⚠️ No article content returned.

..
Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds